Skip to content

Columbia Shoulder Study (CSS)

5- Year Follow-up in Total Shoulder Arthroplasty for Primary Glenohumeral Osteoarthritis: A Prospective Multicenter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01488006
Acronym
CSS
Enrollment
207
Registered
2011-12-08
Start date
2001-04-30
Completion date
2012-11-30
Last updated
2015-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of Glenohumeral Joint

Keywords

Primary Glenohumeral Osteoarthritis, Total shoulder arthroplasty, Total shoulder replacement, Osteoarthritis, Multicenter study

Brief summary

This prospective study will evaluate the Bigliani/Flatow prosthesis. The aims of this study are to establish the safety, effectiveness, and value of the prosthetic system, and to collect information from expert shoulder surgeons as to features of the implants, instruments, and techniques which may be further improved. In this study, the investigators hypothesize that this prosthetic device will significantly improve long-term patient-based outcomes, functional status and quality of life.

Detailed description

Over the last two decades, total shoulder joint replacement - or arthroplasty - has become a commonly performed procedure for the treatment of painful arthritis of the shoulder, and numerous studies have demonstrated its success. During this time, much has been learned about the efficacy, as well as the complications, of the procedure, and since its introduction in the 1950's, shoulder arthroplasty has undergone an evolution in design. The value of such innovations has not yet been determined and will depend on the results of long term follow-up studies. The purpose of this study is to provide follow-up information and design modification directives.

Interventions

DEVICEBigliani/Flatow Shoulder System

Primary Total Shoulder Arthroplasty with the Bigliani/Flatow prosthesis

Sponsors

Zimmer Biomet
CollaboratorINDUSTRY
Columbia University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient must be 18 years of age or over. * Patient must have signed The Informed Consent and Release of Medical Information forms. * The patient can be a man, postmenopausal woman, or a woman who is likely to become pregnant but is using adequate contraceptive precautions (defined as oral contraceptives, intrauterine devices, surgical contraception or a combination of a condom and spermicide). * Patient needs a total shoulder arthroplasty (humeral head and glenoid). * Patient has a diagnosis of primary osteoarthritis.

Exclusion criteria

* Obstacles, which pose an inordinately high surgical risk, in the judgment of the certified surgeon. * Class IV or higher anesthetic risk. * Patient has a recent history of psychiatric disease (including drug or alcohol abuse) that is likely to impair the compliance with the study protocol. * Patient has had a shoulder fracture. * Patient had previous shoulder surgeries with the exception of an arthroscopic debridement procedure. * The patients has a massive rotator cuff tear (rupture \>3 cm or total cicatrisation) demonstrated at time of the surgery that precludes the total shoulder replacement.

Design outcomes

Primary

MeasureTime frameDescription
Preoperative Radiographic Measurements of Standard Glenohumeral RelationshipsUp to 16 weeks prior to date of surgery
Change in Post-operative Radiographic Measurements of Prosthetic Relationships (Anteroposterior and Axillary x-rays)Up to 5 years postoperativelyMeasurements include acromiohumeral interval, head to tuberosity distance, coracoid to glenohumeral joint distance, coracoid to tuberosity distance, humeral stem position (valgus/varus), humeral congruity and subluxation, glenoid comp version.
Change in Radiographic Analysis for Lucent Lines and Prosthesis LooseningUp to 5 year postoperativelyglenoid and humeral component lucency

Secondary

MeasureTime frameDescription
Change in Total Score on Simple Shoulder Test (SST)Up to 5 years postoperatively.Total score.
Change in Score on Short-Form 36 (SF-36)Up to 5 years postoperatively.Mental component score, physical component score, mental health, physical function, role emotional, role physical, social function, vitality, bodily pain and general health
Change in Range of MotionUp to 5 years postoperatively.Active and passive external rotation at 90 degrees and at side, active and passive forward elevation, active and passive abduction, active and passive internal rotation
Change in Constant ScoreUp to 5 years postoperatively.
Change in Score on EuroQOL (EQ-5D)Up to 5 years postoperatively.Total index, visual analog scale, mobility, anxiety/depression, pain/discomfort, self-care, and usual activities.
Change in ASES (American Shoulder and Elbow Surgeons) ScoreUp to 5 years postoperatively.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026